Web Results

immunomedics.com

Immunomedics announces multiple clinical and preclinical collaborations with prominent cancer research institutions. Read More ...

immunomedics.com/our-company/careers/available-positions

Immunomedics typically recruits candidates directly rather than with the ... for us to review, please forward the relevant documentation to Immunomedics, Inc., ...

finance.yahoo.com/quote/IMMU

View the basic IMMU stock chart on Yahoo Finance. Change the date range, chart type and compare Immunomedics, Inc. against other companies.

www.fool.com/investing/2017/12/06/why-immunomedics-inc-is-soaring-today.aspx

Dec 6, 2017 ... After Immunomedics (NASDAQ:IMMU) shared some positive clinical data with investors, shares of the clinical-stage biotech focused on cancer ...

www.fool.com/investing/2017/05/05/why-immunomedics-inc-rocketed-today.aspx

May 5, 2017 ... Immunomedics (NASDAQ:IMMU) is up 18% at 1:11 p.m. EDT after announcing a new plan to develop sacituzumab govitecan on its own, ...

www.nytimes.com/topic/company/immunomedics-inc

Immunomedics Inc. financial and business news, updates, and information from The New York Times and other leading providers.

seekingalpha.com/article/4181346-immunomedics-short-term-risk-long-term-opportunity

Jun 13, 2018 ... About: Immunomedics, Inc. (IMMU) ... Immunomedics (NASDAQ:IMMU) is a clinical-stage biotech pharmaceutical company specializing in ...

www.marketwatch.com/investing/stock/immu

Immunomedics Inc. stock price, stock quotes and financial overviews from MarketWatch.

www.linkedin.com/company/immunomedics

Learn about working at Immunomedics. Join LinkedIn today for free. See who you know at Immunomedics, leverage your professional network, and get hired.